4Life’s product RiteStart Men and RiteStart Women were recently examined in a peer-reviewed clinical study published in the Journal of Alternative Therapies. The study, authored by 4Life’s Research and Development scientists Lawry Han, PhD, FACN; Brent Vaughan, PhD, RD; and Chief Scientific Officer David Vollmer, PhD, explored the effects of the products on important biomarkers in healthy men and women.
The 12-week clinical study returned findings that illustrated RiteStart had “an excellent safety and tolerability profile” and that the supplementation improved serum levels of vitamin D, folate and vitamin B12.
“This study is another example of 4Life’s commitment to advancing transfer factor science and research,” said Vice President of Product Development Dr. Han. “We will continue to study the structure-function benefits of 4Life products and publish whenever possible to remain a world leader.”
